` 002349 (Jinghua Pharmaceutical Group Co Ltd) vs Shanghai Composite Comparison - Alpha Spread
Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

002349
vs
S
Shanghai Composite

Over the past 12 months, Jinghua Pharmaceutical Group Co Ltd has underperformed Shanghai Composite, delivering a return of +2% compared to the Shanghai Composite's +22% growth.

Back to 002349 Analysis

Stocks Performance
002349 vs Shanghai Composite

Loading
002349
Shanghai Composite
Add Stock
www.alphaspread.com
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
002349 vs Shanghai Composite

Loading
002349
Shanghai Composite
Difference
www.alphaspread.com
1Y 3Y 5Y 10Y 15Y 20Y

Performance By Year
002349 vs Shanghai Composite

Loading
002349
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Jinghua Pharmaceutical Group Co Ltd vs Peers

Shanghai Composite
002349
JEF
JNJ
4312
Add Stock
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Jinghua Pharmaceutical Group Co Ltd
Glance View

Market Cap
6.1B CNY
Industry
Pharmaceuticals

Jinghua Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing. The company is headquartered in Nantong, Jiangsu and currently employs 2,065 full-time employees. The company went IPO on 2010-02-03. The firm is also engaged in the provision of traditional Chinese medicinal materials and Chinese herbal pieces, among others. The firm primarily provides tablets, capsules, pills, granules, injections, powder, syrup, healthcare products, beverages and chemical intermediates, among others. The firm offers Chinese patent medicines, such as Wangshi Baochiwan pills and Jidesheng tablets. Its bulk drugs include phenobarbitone and fluorouracil. The firm distributes its products in domestic and overseas markets.

Intrinsic Value
5.24 CNY
Overvaluation 31%
Intrinsic Value
Price
What is Intrinsic Value?
Back to Top
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.